Strong performance in Aerospace & Defense propels sequential growth Q2 2024 sales of $1.1 billion, up 5% from Q1 2024 Q2 2024 net income attributable to ATI of $81.9 million, or $0.58 per share, up 26% from Q1 2024 Aerospace & defense represent 62% of Q2 2024 sales, up from 59% of Q1 2024…

Second Quarter Earnings Growth and Margin Expansion Underpinned by Execution in Aggregates Uniquely Positioned Aggregates Business Supports Full Year Earnings Growth BIRMINGHAM, Ala., Aug. 6, 2024 /PRNewswire/ — Vulcan Materials Company (NYSE: VMC), the nation’s largest producer of…

PHILADELPHIA, Aug. 6, 2024 /PRNewswire/ — Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced its upcoming poster presentation at the American…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.